Maximillian Diehn

42PUBLICATIONS
310CO-AUTHORS
Molecular targetsMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (42)

|Jul 03, 2026
A targetable FTO/SLC7A11/CBS/CTH axis controls cysteine metabolism, growth and survival in NSCLC.

|Jan 06, 2026
AI-enabled virtual spatial proteomics from histopathology for interpretable biomarker discovery in lung cancer.

Zhe Li, Yuchen Li, Jinxi Xiang

|Nov 24, 2025
CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias.

Mark P Hamilton, Nick Phillips, Troy Noordenbos

|Sep 26, 2025
Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma.

Ajay Subramanian, Shengqin Su, Jamie Flerlage

|Aug 13, 2025
Remission Assessment by Circulating Tumor DNA in Large B-Cell Lymphoma.

Mark Roschewski, David M Kurtz, Jason R Westin

|Apr 29, 2025
Integrating ctDNA Analysis and Radiomics for Dynamic Risk Assessment in Localized Lung Cancer.

Everett J Moding, Mohammad Shahrokh Esfahani, Cheng Jin

Pageof 7

Frequent Collaborators

26 joint publications

Ash Alizadeh

12 joint publications

David M Kurtz

9 joint publications

Everett J Moding

8 joint publications

Stefan K Alig